1. Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor – belinostat – in glioblastoma cell lines: a preliminary report
   Magdalena Kusaczuk et al, 2016, Investigational New Drugs CrossRef
2. Sodium 4-phenylbutyric acid prevents murine acetaminophen hepatotoxicity by minimizing endoplasmic reticulum stress
   Hiromi Kusama et al, 2017, Journal of Gastroenterology CrossRef
3. Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS/MS and in silico toxicity prediction
   Lovekesh Mehta et al, 2021, Journal of Liquid Chromatography & Related Technologies CrossRef
4. Role of Apg-1 in HSF1 activation and bortezomib sensitivity in myeloma cells
   Mengyuan Zhu et al, 2020, Experimental Hematology CrossRef
5. The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies
   Mahdieh Mehrpouri et al, 2021, International Immunopharmacology CrossRef
6. Combination Epigenetic Therapy
   Rūta Navakauskienė, 2023, Handbook of Epigenetics CrossRef
7. A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors
   Hanna Bailey et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
8. Combination Epigenetic Therapy
   Rūta Navakauskienė, 2017, Handbook of Epigenetics CrossRef
9. Dominant-negative p53-overexpression in skeletal muscle induces cell death and fiber atrophy in rats
   Henning T. Langer et al, 2022, Cell Death & Disease CrossRef
10. Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer’s Disease
    Michalina Wezyk et al, 2018, Journal of Alzheimer's Disease CrossRef